State AL
Clinical Trials in Alabama
Recruiting clinical trials with at least one study location in Alabama. Data updated daily from ClinicalTrials.gov.
Top Conditions in Alabama
NCT06294548 Phase 1, Phase 2
Recruiting
A Study of Valemetostat Tosylate (DS-3201b) With Atezolizumab and Bevacizumab in...
Condition
Hepatocellular Carcinoma
Enrollment
45 pts
Location
United States
Sponsor
University of Alabama at Birmi
NCT06455085 N/A
Recruiting
RESTORE: REducing Future fractureS and Improving ouTcOmes of fRagility fracturE
Condition
Osteoporosis
Enrollment
2,634 pts
Location
United States
Sponsor
University of Alabama at Birmi
NCT05128955 N/A
Recruiting
Embolization of the Splenic Artery After Trauma
Condition
High-grade Splenic Injuries
Enrollment
250 pts
Location
United States
Sponsor
Andrew J. Gunn
NCT04637763 Phase 1
Recruiting
CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B ...
Condition
Lymphoma, Non-Hodgkin
Enrollment
72 pts
Location
United States, Australia, Israel
Sponsor
Caribou Biosciences, Inc.
NCT04464226 Phase 3
Recruiting
Study to Continue Treatment With Darolutamide in Patients Who Have Been Particip...
Condition
Cancer
Enrollment
402 pts
Location
United States, Argentina, Australia
Sponsor
Bayer
NCT07220213 N/A
Recruiting
FELLAShip to Better Health
Condition
High Blood Glucose
Enrollment
90 pts
Location
United States
Sponsor
University of Alabama at Birmi
NCT03435796 Phase 2, Phase 3
Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Condition
Neoplasms
Enrollment
1,541 pts
Location
United States, Australia, Austria
Sponsor
Celgene
NCT05482126 N/A
Recruiting
Sensory Filtering in the Human Basal Ganglia as a Mechanism of Parkinson's Disea...
Condition
Parkinson Disease
Enrollment
30 pts
Location
United States
Sponsor
University of Alabama at Birmi
NCT06424288 Phase 3
Recruiting
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps Peop...
Condition
Heart Failure
Enrollment
6,000 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
NCT06094010 Phase 3
Recruiting
A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Partic...
Condition
Influenza
Enrollment
750 pts
Location
United States, Bulgaria, Poland
Sponsor
Hoffmann-La Roche
NCT07016412 Phase 2
Recruiting
A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Stud...
Condition
Chronic Obstructive Pulmonary Disease
Enrollment
480 pts
Location
United States
Sponsor
Verona Pharma plc
NCT06854757 N/A
Recruiting
Families Left Behind
Condition
Grief
Enrollment
340 pts
Location
United States
Sponsor
RAND
NCT05701657 N/A
Recruiting
Nutrition for Precision Health, Powered by the All of Us
Condition
Nutrition
Enrollment
8,000 pts
Location
United States
Sponsor
RTI International
NCT06890884 Phase 2
Recruiting
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophos...
Condition
Lymphoma, Large B-Cell, Diffuse
Enrollment
594 pts
Location
United States, Belgium, Germany
Sponsor
Merck Sharp & Dohme LLC
NCT04262206 Phase 4
Recruiting
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
Condition
Cognitive Impairment, Mild
Enrollment
20,000 pts
Location
United States, Puerto Rico
Sponsor
Duke University
NCT06131021 Phase 3
Recruiting
Shaping the Indications for Periodontal Adjunctive Antibiotics in Dental Practic...
Condition
Periodontitis
Enrollment
150 pts
Location
United States
Sponsor
Rutgers, The State University
NCT04642352 N/A
Recruiting
Office-Based Superior Laryngeal Nerve Block for Treatment of Neurogenic Cough
Condition
Cough
Enrollment
50 pts
Location
United States
Sponsor
University of Alabama at Birmi
NCT06388733 Phase 3
Recruiting
A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-d...
Condition
Glioblastoma
Enrollment
450 pts
Location
United States, Australia, Canada
Sponsor
Ivy Brain Tumor Center
NCT06378632 N/A
Recruiting
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE ...
Condition
Heart Failure
Enrollment
500 pts
Location
United States, Israel, Spain
Sponsor
Cordio Medical
NCT06374147 N/A
Recruiting
"Prapela® SVS Incubator Pad for Apnea of Prematurity
Condition
Apnea of Prematurity
Enrollment
140 pts
Location
United States
Sponsor
Tufts Medical Center
NCT01351545 N/A
Recruiting
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord...
Condition
Hematologic Malignancies
Enrollment
99,999 pts
Location
United States
Sponsor
Center for International Blood
NCT05414500 Phase 1
Recruiting
Mogamulizumab and Brentuximab Vedotin in CTCL and Mycosis Fungoides
Condition
Cutaneous T Cell Lymphoma
Enrollment
10 pts
Location
United States
Sponsor
University of Alabama at Birmi
NCT05545501 N/A
Recruiting
Ketone Ester and Salt (KEAS) in Young Adults
Condition
Salt; Excess
Enrollment
35 pts
Location
United States
Sponsor
Indiana University
NCT07116967 Phase 3
Recruiting
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants Wit...
Condition
Plaque Psoriasis
Enrollment
3,040 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
NCT06568367 Phase 3
Recruiting
Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shif...
Condition
Excessive Sleepiness
Enrollment
520 pts
Location
United States, Canada
Sponsor
Axsome Therapeutics, Inc.